Notice for osilodrostat (Recordati Rare Diseases Australia Pty Ltd)
Active ingredients
osilodrostat
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
For the treatment of endogenous Cushing's syndrome in adults
Therapeutic area
Endocrinology